Psoriasiform Dermatitis in a COVID-19 Patient

Psoriasis is a chronic inflammatory papulosquamous disorder which affects around 2% of the world's population. A peak exacerbation in psoriatic symptoms was noted during COVID-19 due to lack of access to dermatological care mixed with heightened emotional stress during the pandemic. This case r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Marlyn, Teymour, Shereen, Ashinoff, Robin, Ghani, Hira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788876/
https://www.ncbi.nlm.nih.gov/pubmed/36567752
http://dx.doi.org/10.1155/2022/1820673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788876/
https://www.ncbi.nlm.nih.gov/pubmed/36567752
http://dx.doi.org/10.1155/2022/1820673

Ejemplares similares